Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants
Clinical trial NCT03512288 · COMPLETED
Trial details
- NCT number
- NCT03512288
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-16
- Primary completion
- 2020-02-11
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.